References
- Robins H. I., Rushing D., Kutz M., Tutsch K. D., Tiggelaar D., Paul D., Spriggs D., Kraemer C., Gillis W., Feierabend C., Arzoomanian R. Z., Longo W., Alberti D., D'Oleire F., Qu R. P., Wilding G., Stewart J. A. Phase I clinical trial of melphalan and 41.8 C whole-body hyperthermia in cancer patients. Journal of Clinical Oncology 1997; 15: 158–164